Tunable Cell Therapies | Sigilon

About Us
- Our Company
- Contact Us
Science
- SLTx PLatform
- Publications
Pipeline
Patients & Caregivers
Press Releases
Inside Sigilon
- Our Culture
- Job Opportunities

Media Coverage

Back to Media Coverage

Tunable Cell Therapies

Sigilon’s allogeneic cell therapy implants offer long-term but flexible dosing.

©2023 SIGILON THERAPEUTICS INC.
A WHOLLY OWNED SUBSIDIARY OF ELI LILLY AND COMPANY 2023
ALL RIGHTS RESERVED

The marks SIGILON THERAPEUTICS, SIGILON, SHIELDED LIVING THERAPEUTICS, SLTX, AFIBROMER, AFIBROTEK, and our logos are trademarks of Sigilon Therapeutics, Inc. in the U.S. and other countries. All other marks are the property of their respective owners. Privacy Policy